Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Eli Lilly Corp. buy gerihouse

Start price
€65.85
05.05.15 / 50%
Target price
€83.00
22.07.15
Performance (%)
19.78%
End price
€78.43
22.07.15
Summary
This prediction ended on 22.07.15 with a price of €78.43. The BUY prediction by gerihouse finished with a performance of 19.78%. gerihouse has a follow-up prediction for Eli Lilly Corp. where he still thinks Eli Lilly Corp. is a Buy. gerihouse has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Eli Lilly Corp. -1.032% -1.032% 107.681% 343.368%
iShares Core DAX® -1.670% -1.001% 10.864% 12.563%
iShares Nasdaq 100 -4.184% -1.145% 37.458% 41.078%
iShares Nikkei 225® -4.967% -5.783% 18.828% 0.655%
iShares S&P 500 -2.834% -0.572% 25.875% 39.960%

According to gerihouse what are the pros and cons of Eli Lilly Corp. for the foreseeable future?

Pros
Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
Future proof or reliable business model
Small cyclical dependencies
Well known brand
Revenue growth >5% per year expected
Cons

Comments by gerihouse for this prediction

In the thread Eli Lilly Corp. diskutieren
Prediction Buy
Perf. (%) 19.78%
Target price 83.000
Change
Ends at 22.07.15

Tolle Dividendenrendite

Hat mir schon mehrmals gefallen! Sicherer Depotwert!

 

Der Pharmakonzern Eli Lilly (ISIN: US5324571083, NYSE: LLY) wird für das zweite Geschäftsquartal 2015 eine Dividende von 50 US-Cents je Aktie ausbezahlen. Im Dezember 2014 erhöhte Eli Lilly seine Dividende um 2 Prozent oder 1 US-Cent auf den aktuellen Betrag. Auf Jahressicht erhalten die Aktionäre 2,00 US-Dollar. Dies entspricht einer aktuellen Dividendenrendite in Höhe von 2,74 Prozent beim derzeitigen Aktienkurs von 73,11 US-Dollar (Stand: 4. Mai 2015).

Eli Lilly zahlt seit 1885 ununterbrochen eine Dividende an seine Investoren aus. Aktionäre erhalten die nächste Dividendenzahlung am 10. Juni 2015 (Record day: 18. Mai 2015). Seit Jahresanfang liegt die Aktie an der Wall Street mit knapp sechs Prozent im Plus.

Eli Lilly and Company gehört zu den weltweit führenden pharmazeutischen Unternehmen und ist seit über 50 Jahren auch in Deutschland vertreten. Im letzten Geschäftsjahr wurde ein Umsatz von 19,6 Mrd. US-Dollar bei einem Ertrag je Aktie in Höhe von 2,23 US-Dollar erwirtschaftet. Für das aktuelle Geschäftsjahr wird ein Gewinn von 2,40 bis 2,50 US-Dollar je Anteilsschein prognostiziert. Das Unternehmen mit Firmensitz in Indianapolis wurde 1876 von dem Pharmakologen, Offizier und Unternehmer Eli Lilly in Indianapolis gegründet

Prediction Buy
Perf. (%) 19.78%
Target price 83.000
Change
Ends at 22.07.15

(Stop Loss Kurs erreicht)

Current prediction by gerihouse for Eli Lilly Corp.

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€546.50
16.11.23
€740.00
16.11.24
25.66%
17:41

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative

Stopped prediction by gerihouse for Eli Lilly Corp.

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€370.05
04.11.22
€610.00
04.11.23
44.17%
05.11.23

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€213.80
18.01.22
€350.00
18.01.23
47.33%
23.09.22

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€173.98
25.01.21
€250.00
25.01.22
23.00%
17.01.22

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€126.32
18.03.20
€150.00
12.10.20
6.54%
12.10.20

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€98.78
13.10.19
€120.00
26.10.19
0.30%
26.10.19

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€104.32
06.09.19
€120.00
13.10.19
-5.58%
13.10.19

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€103.80
24.06.19
€130.79
06.09.19
0.94%
06.09.19

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€102.30
18.04.19
€120.00
24.05.19
3.46%
24.05.19

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€106.63
24.01.19
€126.28
04.04.19
6.26%
04.04.19

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€71.74
10.05.18
€99.22
06.09.18
32.15%
06.09.18

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€68.59
31.08.17
€80.00
10.11.17
3.37%
10.11.17

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€71.74
10.11.16
€85.00
18.04.17
8.26%
18.04.17

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€63.10
24.03.16
€90.00
08.08.16
16.05%
08.08.16

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€71.93
13.10.15
€90.20
04.01.16
4.66%
04.01.16

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€49.89
11.09.14
€60.00
24.11.14
8.90%
24.11.14

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€39.56
09.10.12
€45.00
21.02.13
5.46%
21.02.13

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€34.30
04.07.12
€40.00
05.09.12
8.03%
05.09.12

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative